搜索
10X Genomics Inc
TXG添加自选
48.100USD
+1.050+2.23%
收盘 07-23 16:00（美东）报价延迟15分钟
6.14B总市值
亏损市盈率 TTM
关于 10X Genomics Inc 公司
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
10X Genomics Inc简介
公司代码TXG
公司名称10X Genomics Inc
上市日期Sep 12, 2019
CEOSaxonov (Serge Wilson)
员工数量1306
证券类型Ordinary Share
年结日Sep 12
公司地址6230 Stoneridge Mall Road
城市PLEASANTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94588
电话19254017300
网址https://www.10xgenomics.com/
公司代码TXG
上市日期Sep 12, 2019
CEOSaxonov (Serge Wilson)
10X Genomics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.10M
-2.72%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
378.44K
+2.33%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
105.23K
-11.02%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
37.45K
+23.58%
Dr. Shehnaaz Suliman, M.D.
Dr. Shehnaaz Suliman, M.D.
Independent Director
Independent Director
31.72K
+9.79%
Mr. Alan V. Mateo
Mr. Alan V. Mateo
Independent Director
Independent Director
--
--
Dr. Sarah A. Teichmann
Dr. Sarah A. Teichmann
Independent Director
Independent Director
--
--
Mr. Adam S. Taich
Mr. Adam S. Taich
Chief Financial Officer
Chief Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.10M
-2.72%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
378.44K
+2.33%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
105.23K
-11.02%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
37.45K
+23.58%
常见问题
10X Genomics Inc的前五大股东是谁？
10X Genomics Inc 的前五大股东如下：Mr. Serge Wilson Saxonov, Ph.D.
有多少机构持有10X Genomics Inc(TXG)的股份？
截至2026Q1，共有726家机构持有10X Genomics Inc的股份，合计持有的股份价值约为140.84M，占公司总股份的118.45%。与2025Q4相比，机构持股有所增加，增幅为-2946322.00。
哪个业务部门对10X Genomics Inc的收入贡献最大？
在2026Q1，Consumables业务部门对10X Genomics Inc的收入贡献最大，创收507.18M，占总收入的78.90%。